Your browser doesn't support javascript.
loading
mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression.
Averill, Lynnette A; Averill, Christopher L; Gueorguieva, Ralitza; Fouda, Samar; Sherif, Mohamed; Ahn, Kyung-Heup; Ranganathan, Mohini; D'Souza, Deepak Cyril; Southwick, Steven M; Sanacora, Gerard; Duman, Ronald S; Krystal, John H; Abdallah, Chadi G.
Afiliação
  • Averill LA; Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA; Menninger Department of Psychiatry, Baylor College of Medicine, Houston, TX, USA; US Department of Veterans Affairs, National Center for PTSD - Clinical Neuroscience Division, West Haven, CT, USA; Department of Psychiatry, Yale Un
  • Averill CL; Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA; Menninger Department of Psychiatry, Baylor College of Medicine, Houston, TX, USA; US Department of Veterans Affairs, National Center for PTSD - Clinical Neuroscience Division, West Haven, CT, USA; Department of Psychiatry, Yale Un
  • Gueorguieva R; Department of Biostatistics, Yale University School of Public Health, New Haven, CT, USA.
  • Fouda S; US Department of Veterans Affairs, National Center for PTSD - Clinical Neuroscience Division, West Haven, CT, USA; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • Sherif M; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Carney Institute for Brain Science, Brown University, Providence, RI, USA.
  • Ahn KH; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • Ranganathan M; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • D'Souza DC; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • Southwick SM; US Department of Veterans Affairs, National Center for PTSD - Clinical Neuroscience Division, West Haven, CT, USA; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • Sanacora G; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • Duman RS; US Department of Veterans Affairs, National Center for PTSD - Clinical Neuroscience Division, West Haven, CT, USA; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • Krystal JH; US Department of Veterans Affairs, National Center for PTSD - Clinical Neuroscience Division, West Haven, CT, USA; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • Abdallah CG; Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA; Menninger Department of Psychiatry, Baylor College of Medicine, Houston, TX, USA; US Department of Veterans Affairs, National Center for PTSD - Clinical Neuroscience Division, West Haven, CT, USA; Department of Psychiatry, Yale Un
J Affect Disord ; 303: 91-97, 2022 04 15.
Article em En | MEDLINE | ID: mdl-35101523
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior / Ketamina Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Affect Disord Ano de publicação: 2022 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior / Ketamina Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Affect Disord Ano de publicação: 2022 Tipo de documento: Article País de publicação: Holanda